Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07304505 · ClinicalTrials.gov registry record · NA

Probiotics in Adults With Rheumatoid Arthritis

A NA study of Rheumatoid Arthritis (RA), sponsored by Ancilia Biosciences.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT07304505 is a NA study of Rheumatoid Arthritis (RA) that is actively recruiting participants, run by Ancilia Biosciences. The registered enrollment target is 50 participants, below the 265-participant average among 17 other Rheumatoid Arthritis (RA) trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07304505, a NA study of Rheumatoid Arthritis (RA), is actively recruiting participants, sponsored by Ancilia Biosciences.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical study is to collect data on the effect of probiotic administration on clinical outcomes in rheumatoid arthritis patients. Participants will: * Have a 6-week daily administration of a probiotic * Collect fecal samples every other day during the first 3 weeks of the study and twice weekly over the last 3 weeks * Visit the clinic at Baseline, Week 3 and Week 6 for checkup and testing

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Align Extra Strength Probiotic Supplement

Study Locations (1)

Illinois

  • Atlantia Clinical Trials - Chicago

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2025-11-13
Est. Completion 2026-03
Phase NA

Sponsor

Ancilia Biosciences

1 total trials

What the Registry Record Tells You About NCT07304505

The ClinicalTrials.gov registry entry for NCT07304505 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 265-participant average among 17 other Rheumatoid Arthritis (RA) trials with a reported enrollment target (81% lower). The listed sponsor is Ancilia Biosciences, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Rheumatoid Arthritis (RA) appearing as the primary indexed condition, and to 1 intervention - of which Align Extra Strength Probiotic Supplement is the first listed.

NCT07304505 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT07304505 about?

NCT07304505 is a clinical study titled "Probiotics in Adults With Rheumatoid Arthritis". The goal of this clinical study is to collect data on the effect of probiotic administration on clinical outcomes in rheumatoid arthritis patients. Participants will: * Have a 6-week daily administration of a probiotic * Collect fecal samples every other day during the first 3 weeks of the study a...

What is the current status of trial NCT07304505?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2025-11-13. Estimated completion is 2026-03.

What conditions does trial NCT07304505 study?

This clinical trial studies the following conditions: Rheumatoid Arthritis (RA).

What interventions are being tested in trial NCT07304505?

The interventions under investigation include: Align Extra Strength Probiotic Supplement (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT07304505?

This trial is sponsored by Ancilia Biosciences, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07304505 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Rheumatoid Arthritis (RA)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.